Arterial Remodeling Technologies Reports That its Second-generation Bioresorbable Stent Promotes Vessel Lumen Enlargement in Post-angioplasty in Vivo Model  
11/2/2011 9:11:08 AM

PARIS--(BUSINESS WIRE)--Arterial Remodeling Technologies (“ART”) reported today that in vivo data strongly suggest that its second-generation bioresorbable stent promotes positive arterial remodeling in a post-angioplasty porcine model at three months follow-up. In addition, acute safety data are excellent: there have been more than 250 MACE-free consecutive implantations of its bioresorbable stent in its preclinical phase of development.